国家: 澳大利亚
语言: 英文
来源: Department of Health (Therapeutic Goods Administration)
nicotine polacrilex, Quantity: 10 mg (Equivalent: nicotine, Qty 2 mg)
Johnson & Johnson Pacific Pty Ltd
Lozenge
Excipient Ingredients: sodium carbonate; xanthan gum; mannitol; polysorbate 80; acesulfame potassium; hypromellose; sucralose; titanium dioxide; magnesium stearate; purified water; Flavour; stearic acid; mica
Buccal
8x20 Lozenges, 20 Lozenges, 4x20 Lozenges
Not scheduled. Not considered by committee
For the treatment of tobacco dependence by relieving nicotine craving and withdrawal symptoms, thereby facilitating smoking cessation in smokers motivated to quit. In smokers unable or not ready to stop smoking abruptly, the lozenge may also be used as part of a smoking reduction strategy as a step towards stopping completely.
Visual Identification: An oval, white to off-white film-coated lozenge, imprinted with ?n? on one side and ?2? on the other side.; Container Type: Bottle; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius
Licence status A
2017-11-03